Ethylene

Ethylene

SCHEMBL8169366

C=C.CCOC(C)OCC.O=Cc1cccc(OCCBr)c1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 7/20 0.44
MAOB P27338 7/20 0.44
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
TLR4 O00206 1/20 0.39
TLR2 O60603 1/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SRC P12931 1/20 0.37
TSHR P16473 2/20 0.36
MAPK1 P28482 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
APP P05067 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1607743 0.84 MAOA (0.58) MAOAMAOBNPC1RAB9ATDP1
SCHEMBL25518732 0.80 MAOA (0.47) MAOAMAOBNPC1RAB9ATDP1
Ethylene SCHEMBL3645192 0.79 ALDH1A1 (0.59) MAOAMAOBALDH1A1SMN1; SMN2CYP1A2
SCHEMBL9632142 0.78 MAOA (0.49) MAOAMAOBNPC1RAB9ATDP1
SCHEMBL585629 0.76 MAOA (0.57) MAOAMAOBNPC1RAB9ATDP1
Ethylene SCHEMBL233909 0.76 TP53 (0.39) MAOAMAOBNPC1RAB9ATDP1
SCHEMBL6712899 0.76 ALDH1A1 (0.62) MAOAMAOBALDH1A1SMN1; SMN2CYP1A2
SCHEMBL15941682 0.75 MAOA (0.55) MAOAMAOBNPC1RAB9ATDP1
SCHEMBL29955687 0.75 MAOA (0.58) MAOAMAOBNPC1RAB9ATDP1
SCHEMBL910596 0.75 MAOA (0.58) MAOAMAOBNPC1RAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6124323-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed